GEFTIB Tablets are indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited.
GEFTIB 250 ........ pack of 3x10 Tablets